Unnati Pharmacuticals Profile
Key Indicators
- Authorised Capital ₹ 1.05 M
- Paid Up Capital ₹ 0.90 M
- Company Age 21 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.60 Cr
- Revenue Growth -2.93%
- Profit Growth -46.70%
- Ebitda -26.81%
- Net Worth 7.90%
- Total Assets 3.65%
About Unnati Pharmacuticals
Unnati Pharmacuticals Private Limited (UPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 24 June 2003 and has a history of 21 years and seven months. Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Chemicals And Resources Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.05 M and a paid-up capital of Rs 0.90 M.
The company currently has active open charges totaling ₹13.60 Cr.
Hetal Mehta and Naishil Mehta serve as directors at the Company.
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24231GJ2003PTC042538
- Company No.
042538
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jun 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Unnati Pharmacuticals Private Limited offer?
Unnati Pharmacuticals Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antispasmodic Drugs.
Who are the key members and board of directors at Unnati Pharmacuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naishil Mehta  | Director | 21-Dec-2016 | Current |
| Hetal Mehta | Director | 30-Jun-2010 | Current |
Financial Performance of Unnati Pharmacuticals.
Unnati Pharmacuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.93% decrease. The company also saw a substantial fall in profitability, with a 46.7% decrease in profit. The company's net worth moved up by a moderate rise of 7.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unnati Pharmacuticals?
In 2023, Unnati Pharmacuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹135.97 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 13.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Mar 2022 | Hdfc Bank Limited | ₹1.33 M | Open |
| 12 Mar 2018 | Hdfc Bank Limited | ₹5.00 Cr | Open |
| 28 Feb 2008 | Hdfc Bank Limited | ₹8.46 Cr | Open |
How Many Employees Work at Unnati Pharmacuticals?
Unlock and access historical data on people associated with Unnati Pharmacuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unnati Pharmacuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unnati Pharmacuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
